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Abstract
Inhalation of Yersinia pestis causes primary pneumonic plague, a highly lethal syndrome with mortality rates approaching
100%. Pneumonic plague progression is biphasic, with an initial pre-inflammatory phase facilitating bacterial growth in the
absence of host inflammation, followed by a pro-inflammatory phase marked by extensive neutrophil influx, an
inflammatory cytokine storm, and severe tissue destruction. Using a FRET-based probe to quantitate injection of effector
proteins by the Y. pestis type III secretion system, we show that these bacteria target alveolar macrophages early during
infection of mice, followed by a switch in host cell preference to neutrophils. We also demonstrate that neutrophil influx is
unable to limit bacterial growth in the lung and is ultimately responsible for the severe inflammation during the lethal pro-
inflammatory phase.
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Introduction
The historical impact of Yersinia pestis on humanity cannot be
understated, as three major pandemics including the ‘‘Black
Death’’ of the Middle Ages have been attributed to Y. pestis [1,2].
The bacterium can be transmitted person-to-person via respira-
tory droplets resulting in primary pneumonic plague, which is the
deadliest manifestation of Y. pestis infection [1,2,3]. In the event of
respiratory exposure in humans, mortality rates are nearly 100%
with a time to death of typically between four and seven days [1].
Its extreme lethality and history of weaponization have led to the
assignment of Y. pestis as a Tier 1 Select Agent and compound fears
of its intentional release as a weapon of bioterrorism [1].
Using a murine intranasal infection model, our laboratory
demonstrated that the primary pneumonic plague syndrome
progresses in two distinct phases [4]: an initial ‘‘pre-inflammatory
phase’’ characterized by rapid bacterial replication in the lung in
the absence of host innate immune responses, followed by a ‘‘pro-
inflammatory’’ phase marked by extensive neutrophil influx, a
massive pro-inflammatory cytokine storm, and considerable tissue
destruction within the lung. In mice and humans, progression into
this pro-inflammatory phase invariably results in death without
immediate treatment [5,6]. Recently, our laboratory showed that
Y. pestis creates a unique protective environment in the lungs of
mice that allows for the growth of typically avirulent organisms
[7], suggesting that Y. pestis suppresses host innate immune
responses in the lung early during infection. The mechanism and
host cell types involved in this phenomenon remain unknown.
Y. pestis utilizes a plasmid-encoded type III secretion system
(T3SS) to deliver Yersinia effector proteins (Yops) directly to the
cytosol of target cells. Injection of Yop effectors is essential for Y.
pestis virulence and is known to have anti-inflammatory and anti-
phagocytic effects on mammalian cells [2,8,9]. The pulmonary
cells targeted by Y. pestis during primary pneumonic plague have
yet to be identified. In the work presented here, we use fully
virulent Y. pestis CO92 expressing a YopE-TEM b-lactamase
hybrid protein to identify the host cells targeted in the lung, and to
evaluate the effect of depletion of these cell types on the
progression of pneumonic plague. We show that the Y. pestis
T3SS primarily targets macrophages and neutrophils early during
the pre-inflammatory phase of disease. We also monitor the host
cell dynamics in the lung in response to Y. pestis challenge and
show that neutrophils are ultimately responsible for the severe
necrotizing pneumonia during the pro-inflammatory disease
phase. This work is the first identification/evaluation of the host
cells targeted by fully virulent Y. pestis in the lung, and the results
give insight into the dynamic events occurring shortly after
pulmonary exposure to the highly lethal pathogen Y. pestis.
Results
Injection by the T3SS is detectable in vivo during primary
pneumonic plague
Y. pestis injection of Yop effector proteins is essential for
virulence during plague. We sought to evaluate in vivo injection of
Yop effector proteins in the lung using a murine intranasal model
of Y. pestis infection. Chimeric Yop-TEM b-lactamase proteins
have been used previously to demonstrate Yop translocation into
target cells of the spleen and lymph nodes in vivo and tissue culture
macrophages in vitro [10,11,12]. Briefly, host cells or tissues are
infected with Y. pestis harboring a Yop-TEM translational fusion,
followed by staining of cells with the fluorescent substrate CCF2-
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AM (Invitrogen). CCF2-AM is a cephalosporin conjugated to the
fluorophores coumarin and fluorescein that exhibit fluorescence
resonance energy transfer (FRET). Uninfected mammalian cells
harboring CCF2-AM can be detected as green fluorescence
emission (520 nm); cells that have been targeted for Yop
translocation will fluoresce blue (447 nm) due to cleavage of
cytosolic CCF2-AM (and disruption of FRET) by the b-lactamase
moiety of Yop-TEM. We constructed a strain of Y. pestis CO92 (Y.
pestis YopE-TEM) that expresses both wild-type YopE and the N-
terminal 100 amino acids of YopE fused to TEM b-lactamase.
YopE is a GTPase activating protein that is highly secreted in vitro
and is known to inhibit phagocytosis through the disruption of
actin microfilaments [8,9]. Incorporation of the YopE-TEM b-
lactamase fusion had no effect on the virulence of Y. pestis CO92 as
determined by bacterial burden, cytokine, and histopathological
analysis.
To evaluate YopE-TEM injection in vivo, C57BL/6J mice were
inoculated with 106 CFU of Y. pestis YopE-TEM, and single-cell
suspensions were generated from infected lungs at 12 hpi for
evaluation by flow cytometry [13]. Lung suspensions stained with
CCF2-AM uniformly exhibited green fluorescence compared to
unstained samples (Figure 1A). In contrast to mice inoculated with
PBS alone, mice infected with Y. pestis YopE-TEM exhibited blue
fluorescence in a subset of cells (3% of total cells), indicating that
YopE-TEM-mediated cleavage of CCF2-AM was detectable in vivo
by flow cytometry (Figure 1A). For a more detailed analysis, groups
of mice were sacrificed at 6, 12, and 24 hpi for flow cytometry
evaluation of blue fluorescence. At 6 hpi, roughly 26104 injection
events per mouse were detected, representing approximately 1% of
total recovered cells (Figure 1B,C). This number increased over
time, reaching roughly 36106, or 48% of total recovered cells by
24 hpi (Figure 1B,C). The approximately 100-fold increase in
injection events coincided with a nearly 100-fold increase in
bacterial burden (Figure 1D). These data demonstrate that Y. pestis
secretion of effectors occurs early during pneumonic plague, and is
detectable in the lung using flow cytometry.
Y. pestis targets alveolar macrophages and neutrophils
early during primary pneumonic plague
The ability of Y. pestis to create a localized protective
environment in the lungs early during pneumonic plague suggests
that it deactivates host innate immune responses [7]. We
hypothesized that Y. pestis targets innate immune cell populations
early in the lung via type III secretion of Yop effectors. In order to
examine the host cell types intoxicated early during infection, mice
were sacrificed at 6, 12, and 24 hpi, and whole lung cell
suspensions were incubated with CCF2-AM as well as fluores-
cently labeled anti-CD45 and anti-CD3 antibodies. Cells exhib-
iting blue fluorescence were gated and analyzed to distinguish
between lymphocyte (CD45+CD3+), leukocyte (CD45+CD32),
and epithelial/endothelial (CD452CD32) cell populations. At
each of the time points examined, .96% of injection events
occurred in a population of CD45+CD32 cells, indicating that
innate immune leukocyte populations were the primary targets for
Y. pestis translocation of YopE-TEM (Figure S1B). By 24 hpi
roughly 40% of CD45+CD32 cells were injected with YopE-
TEM, whereas less than 3% of the other two populations were
injected (Figure S1C).
To identify the leukocyte cell populations targeted by Y. pestis,
lungs of mice infected with Y. pestis YopE-TEM were incubated with
CCF2-AM as well as a panel of fluorescently labeled antibodies to
cell type-specific markers. Viable cells exhibiting blue fluorescence
were gated and analyzed based on fluorescence staining patterns to
identify alveolar macrophages, CD11bhigh interstitial/exudate
macrophages, F4/80+CD11bhigh CD11chigh macrophages, mono-
cytes, CD11bhigh and CD11blow dendritic cells (DCs), and
neutrophils (Figure S2A). At 6 hpi, alveolar macrophages repre-
sented roughly 55% of injected cells (Figure 1E). Neutrophils and
cells that are unidentifiable based on our antibody panel (‘‘other’’)
were the next most prominent target populations, each representing
roughly 18% of injected cells. At 12 hpi a dramatic switch in host
cell preference occurred, where greater than 70% of injected cells
were neutrophils and alveolar macrophages represented less than
10% of injected cells (Figure 1E). By 24 hpi approximately 90% of
injected cells were neutrophils, and more than 60% of all recovered
neutrophils were positive for YopE-TEM translocation (Figure
S2B). In summary, Y. pestis initially injects effector Yops into resident
alveolar macrophages during pneumonic plague, followed by a shift
in host cell preference to neutrophils.
The shift in Y. pestis host cell preference corresponds
with an influx of neutrophils into the lung
Understanding how the preferred cellular targets of Y. pestis
change over time also demands that we assess the host cell
repertoire within the infected lung. Flow cytometry analysis
revealed increased numbers of neutrophils as early as 6 hpi that
reached roughly 50 times those of mock-infected mice by 24 hpi
(Figure 2A). Infected mice also showed elevated levels of
CD11bhigh DCs as well as F4/80+CD11bhighCD11chigh cells that
continued to increase throughout the duration of the pre-
inflammatory phase of disease (Figure 2A). Histological analysis
of infected lungs showed that the influx of neutrophils resulted in
minimal changes in lung pathology at 24 hpi, and small, localized
areas of inflammatory infiltrate were found sporadically through-
out infected lung sections (Figure 2B). These animals displayed no
outward symptoms of disease at this time point. This is in contrast
to what was seen at 48 hpi, where large, densely packed
inflammatory foci were visible throughout a majority of infected
lung sections (Figure 2B), and animals began to show disease
symptoms including lethargy and decreased responses to stimuli.
Thus, despite a lack of disease symptoms and a minimal level of
detectable changes in lung pathology, there was an increase in
bacterial burden as well as an expansion of neutrophils and other
innate immune cell populations in the lung during the pre-
inflammatory phase of disease.
Author Summary
Inhalation of the bacterium Yersinia pestis results in
primary pneumonic plague, a severe necrotizing pneumo-
nia with mortality rates approaching 100% in the absence
of timely antibiotic administration. Despite the notoriety of
Y. pestis as a potential biological weapon and its well-
established pandemic potential, very little is known
regarding early host-pathogen interactions that lead to
the progression of pulmonary infection. Y. pestis harbors a
type III secretion system (T3SS) for delivery of Yersinia
outer protein (Yop) effectors into host cells, an early and
essential step in pathogenesis. In the work presented here,
we identify the host cell targets of Y. pestis Yop secretion in
the lung. We show that Y. pestis initially targets alveolar
macrophages, followed by a shift in host cell preference to
neutrophils. Through cellular depletion studies, we dem-
onstrate that Y. pestis is highly resistant to macrophage-
and neutrophil-mediated clearance, and that the accumu-
lation of neutrophils in the lung is responsible for the
severe necrotizing pneumonia that develops during the
pro-inflammatory phase of pneumonic plague.
Host Targets of Yersinia during Pneumonic Plague
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The abundance of neutrophils dictates levels of YopE
injection
At 6 hpi, alveolar macrophages represented the primary cell
population targeted by Y. pestis type III secretion (Figure 1E). We
next sought to evaluate the effect of alveolar macrophage depletion
on YopE injection. Clodrosome is a multilamellar liposome
suspension encapsulating the drug clodronate (Encapsulum).
Liposomal clodronate has been used previously to deplete alveolar
Figure 1. YopE-TEM translocation in the lung during pneumonic plague. (A) Groups of mice were inoculated intranasally with 106 CFU of Y.
pestis expressing YopE-TEM or PBS alone (mock), followed by staining with CCF2-AM. Lungs were harvested at 12 hpi, and live cells were gated to
evaluate blue/green fluorescence by flow cytometry. Cells showing blue fluorescence have been injected with YopE-TEM. Histograms show
representative data from a single mouse; (B) Total injection events (cells exhibiting blue fluorescence) in the lungs of mice inoculated with 106 CFU Y.
pestis YopE-TEM; (C) The percentage of total cells in the lung injected with YopE-TEM was evaluated for samples shown in (B) at 6, 12, and 24 hpi; (D)
Lung bacterial burden was evaluated in mice inoculated with 106 CFU Y. pestis YopE-TEM. (E) Live injected cells in lungs of mice inoculated with
106 CFU Y. pestis YopE-TEM were gated for identification of alveolar macrophages (F480+CD11blow/midCD11chigh), interstitial macrophages
(F480+CD11bhighCD11cmid/low), F480+CD11bhighCD11chigh macrophages, monocytes (F4802CD11bhighLy-6G2), neutrophils (F4802CD11bhighLy-6G+),
and CD11b high and low dendritic cells (F4802 CD11c+); All data are representative of at least three independent experiments with three to five mice
at each time point. Error bars represent SEM.
doi:10.1371/journal.ppat.1003679.g001
Host Targets of Yersinia during Pneumonic Plague
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macrophages by distillation via the intranasal route [14,15,16]. In
order to evaluate Y. pestis early interactions with alveolar
macrophages, mice were treated with clodrosome for two days
prior to inoculation with Y. pestis YopE-TEM. Intranasal
administration of clodrosome resulted in a roughly 92% decrease
in alveolar macrophages relative to uninoculated mice (Figure
S3A,B). The targeted depletion of alveolar macrophages resulted
in a roughly 1.7-fold decrease in total YopE-TEM injection events
at 6 hpi (Figure 3A). Analysis of injected cells revealed that with
limited numbers of alveolar macrophages available, the primary
injected cell type shifted to neutrophils, which represented greater
than 60% of injected cells (Figure 3C). This is in contrast to what is
seen in untreated mice, where at 6 hpi alveolar macrophages
represented roughly 55% of injected cells and neutrophils
represented less than 3%.
We sought to determine if the abundance of neutrophils at
24 hpi was the primary factor responsible for an overall increase in
injection events. To evaluate levels of YopE-TEM injection in the
absence of neutrophils, mice were injected intravenously 24 hours
prior to infection with depleting antibody to the lymphocyte
antigen 6 complex (Ly-6G). Ly-6G is expressed on the majority of
myeloid cells in the bone marrow and peripheral granulocytes, and
the use of depleting antibody clone 1A8 has been shown to
specifically deplete neutrophils [17,18]. Treatment with a-Ly-6G
antibody resulted in a 99% decrease in F4/802 Ly-6G+ cells
(Figure S4A,B), and a 90% decrease in total F4/802 Gr-1+ cells
(data not shown) in the lung while having a minimal impact on
other host cell populations, suggesting the efficient and specific
depletion of lung neutrophils. The absence of neutrophils resulted
in a .10-fold decrease in total injection events at 24 hpi
(Figure 3B). Though depletion of neutrophils resulted in an
increase in the representation of other cell types in the injected
population, neutrophils remained the most prominent host cell
target (Figure 3D). This indicates that neutrophils are the
Figure 2. Lung host cell repertoire of mice inoculated intranasally with Y. pestis. (A) Total cell numbers of innate immune cell populations
in the lungs of mice inoculated with 106 CFU Y. pestis YopE-TEM or PBS (mock) at 6, 12, and 24 hpi. (B) Y. pestis causes severe inflammation in the
lungs that is visible by 48 hpi. Mice were inoculated with 106 CFU Y. pestis and lungs were inflated with 10% formalin at 24 and 48 hpi prior to H and
E staining. Images are representative of experiments done a minimum of three times. Data are representative of at least three independent
experiments with five mice at each time point. Error bars represent SEM.
doi:10.1371/journal.ppat.1003679.g002
Host Targets of Yersinia during Pneumonic Plague
PLOS Pathogens | www.plospathogens.org 4 October 2013 | Volume 9 | Issue 10 | e1003679
preferred host cell target, as their depletion resulted in an overall
decrease in total injection events and failed to result in the
emergence of an additional single cell type as the primary target.
In summary, there is an influx of neutrophils into the lung shortly
after inoculation with Y. pestis, and as a result, the primary host cell
target in the lung shifts from resident alveolar macrophages to
neutrophils.
Depletion of neutrophils attenuates primary pneumonic
plague progression in the lung
In order to determine the roles of macrophages and neutrophils
in the progression of infection, we evaluated the effects of host cell
depletion of each on the progression of primary pneumonic
plague. Depletion of alveolar macrophage populations had little
effect on bacterial survival in the lung as indicated by bacterial
Figure 3. Pre-treatment of mice with clodrosome or neutrophil-depleting antibody a-Ly-6G. (A) Total YopE-TEM injection events 6 hpi in
mice inoculated with 106 CFU Y. pestis YopE-TEM with and without prior alveolar macrophage depletion with clodrosome. (B) Total YopE-TEM
injection events 24 hpi in Y. pestis-infected mice with and without pre-treatment with neutrophil-depleting antibody. (C) Identity of injected cells
6 hpi in mice with and without prior clodrosome treatment. (D) Identity of injected cells 24 hpi with and without pre-treatment with neutrophil-
depleting antibody. Data are representative of at least three independent experiments with three to five mice at each time point. Error bars represent
SEM for all graphs.
doi:10.1371/journal.ppat.1003679.g003
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burden analysis at 24 and 48 hpi (Figure 4A). Infected mice pre-
treated with clodrosome exhibited a similar time-to-death as
untreated infected mice (Figure S5A), and symptoms appeared
identical to untreated infected animals at 48 hpi. Histopathology
of infected mouse lungs from mice pre-treated with clodrosome
revealed the presence of inflammatory foci at 48 hpi that were
similar to those in untreated mice (Figures 4B, S5B). These data
indicate that depletion of greater than 90% of alveolar macro-
phages in the lung changed the initial host cell target, but had little
effect on progression of primary pneumonic plague.
As neutrophils were the primary host cell target of Y. pestis type
III secretion (Figure 1E), we hypothesized that depletion of
neutrophils would hasten disease progression and enhance
bacterial proliferation. Mice pre-treated with a-Ly-6G depleting
antibody were infected with the minimum lethal dose of 104 CFU
of Y. pestis and sacrificed at 48 hpi to determine bacterial burdens
in the lung. Depletion of greater than 99% of neutrophil
populations had no effect on bacterial burdens the lung at
48 hpi (Figure 4A) and extended mean time-to-death of infected
animals by approximately 7 hours, though this difference is not
statistically significant (Figure S5A). Surprisingly, mice that were
pretreated with a-Ly-6G showed no outward disease symptoms at
48 hpi, whereas untreated infected mice showed increased
lethargy and a decreased response to stimuli. Histological
Figure 4. Evaluating the progression of pneumonic plague in mice pre-treated with clodrosome or neutrophil-depleting antibody
a-Ly-6G. (A) Lung bacterial burden in mice with and without pre-treatment with clodrosome or neutrophil-depleting antibody and after inoculation
with 104 CFU Y. pestis; (B) Lung histology 48 hpi in mice inoculated with 104 CFU Y. pestis with and without prior treatment with clodrosome or
neutrophil-depleting antibody. Bar graph represents experiments repeated at least three times with three to five mice. Error bars represent SEM.
Histopathology shows representative images from experiments repeated at least twice.
doi:10.1371/journal.ppat.1003679.g004
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evaluation of lungs of infected mice pre-treated with Ly-6G
antibody revealed a dramatic decrease in the magnitude and
overall area of inflammatory foci compared to that seen in
untreated animals (Figures 4B, S5B). Further, whereas the foci
found in wild-type infected lungs 48 hpi were densely packed with
neutrophils and beginning to lose alveolar structure, lung sections
from a-Ly-6G-treated mice demonstrated foci with intact alveolar
architecture primarily consisting of bacteria with minimal
neutrophil infiltrate (Figure 4B). These data indicate that
neutrophils are the primary cell type responsible for the dramatic
necrotizing pneumonia attributed to the pro-inflammatory phase
of disease. In summary, depletion of neutrophils did not enhance
disease, but rather limited progression into the lethal pro-
inflammatory phase of pneumonic plague.
Discussion
The work presented here is the first to identify the initial host
cell targets of fully virulent Y. pestis during pulmonary infection.
Using flow cytometry to monitor injection of a YopE-TEM fusion
protein by the T3SS, we showed that Y. pestis initially targets
CD11chigh alveolar macrophages and neutrophils in the lung.
Previously, Bosio et al. demonstrated that the attenuated (pgm-
pCD1-) Y. pestis strain A1122 was taken up by a distinct CD11c+
CD11b2 host population in the lungs following intratracheal
inoculation, confirming that Y. pestis initially encounters alveolar
macrophages early during infection [14]. By 12 hpi there is a
dramatic shift in host target cell preference from macrophages to
neutrophils that continues to increase by 24 hpi. This corresponds
with a massive influx of neutrophils into the lung that is detected as
early as 6 hpi. In addition to neutrophils, flow cytometry analysis
of infected lungs revealed a 10-fold increase in numbers of
CD11bhigh DCs by 24 hpi. CD11bhigh DCs are known to
accumulate in airways adjacent to alveolar spaces after allergen
challenge, and have been implicated in the events that define
asthma as well as contributing to CD4+ T-cell priming [19,20].
Infected lungs also saw an overall increase in levels of F4/
80+CD11b+CD11c+ cells. These cells exhibited positivity for both
interstitial (CD11b+) and alveolar (CD11c+) macrophage markers
and were not targeted by clodrosome in uninfected mice. This
population likely consists of a subset of dendritic cells expressing
F4/80, activated alveolar macrophages expressing CD11b, and
macrophages that have entered the lung in response to bacterial
challenge and are induced to express CD11c [21]. Taken together,
these results outline a highly dynamic lung environment early
during infection where different host innate immune populations
are expanding in the lung in an attempt to control Y. pestis
infection, albeit without much success. Despite the expansion of
these cell types, macrophages and neutrophils remained the
primary targets of YopE injection.
The Y. pestis specificity for injection of macrophages and
neutrophils cannot be explained by abundance alone, as the
mammalian respiratory tract is comprised of dozens of host cell
types with direct access to the airways. We observed minimal
injection of CD452CD32 epithelial/endothelial populations at
each of the time points examined, despite the fact that this includes
alveolar epithelial type I cells which are known to cover roughly
95% of the surface area of the alveoli [22]. Depletion of
approximately 92% of alveolar macrophages hastened the shift
in target cells seen during normal infection but resulted in only
slight increases in levels of injection for other cell types, even
though the abundance of these populations was roughly equivalent
to that of neutrophils. Conversely, the depletion of roughly 99%
of neutrophils in the lung prior to infection resulted in a roughly
10-fold decrease in total injection events. This is similar to what
was seen for the enteric pathogen and recent Y. pestis ancestor Y.
pseudotuberculosis, where depletion of neutrophils resulted in a
significant overall decrease in total translocation events in Peyer’s
patches of orogastrically inoculated mice [10]. After treatment
with a-Ly-6G antibody, neutrophils remained the primary host
cell target. It is known that neutrophils can regenerate rapidly,
particularly in the bone marrow, which may partly explain the
failed emergence of an additional preferred cell target after
depletion of lung neutrophils [23]. The targeting of professional
phagocytes, specifically neutrophils, has been seen in other
bacterial species and may represent a common virulence
mechanism for pathogens harboring a functional T3SS
[10,24,25]. P. aeruginosa has been shown to target macrophages
and neutrophils in the lung [24], and Salmonella enterica has been
shown to target neutrophils in the spleen via type III secretion to
promote intracellular survival [25]. This phenomenon also occurs
in other organs of the body during Yersinia infection. In the first
example of in vivo detection of Yop translocation via a Yop-b-
lactamase fusion, Marketon et al. showed that the attenuated Y.
pestis pgm2 strain KIM D27 targeted CD11b+, CD11c+, and Gr-1+
cells in the spleen when delivered intravenously, suggesting
targeting of macrophages, dendritic cells, and neutrophils [12].
It will be intriguing to compare the injected host cell repertoire of
Y. pestis delivered via additional routes of infection, including
subcutaneous and intradermal, and in other tissues including
lymph nodes and in the skin.
As alveolar macrophages and neutrophils are the primary
targets of Y. pestis type III secretion, we sought to further evaluate
their roles during pulmonary infection. Depletion of roughly 92%
of alveolar macrophages had little or no effect on bacterial burden
in the lung. This indicates that either macrophages are not
involved in limiting Yersinia survival in the lung, or that Y. pestis is
able to neutralize the anti-bacterial effects of sentinel alveolar
macrophages, presumably as a result of antiphagocytic/anti-
inflammatory factors including the Yops, F1 capsular protein, and
pH 6 antigen [2]. Also, depletion of alveolar macrophages did not
significantly alter progression into the pro-inflammatory phase of
disease. Infected animals demonstrated typical disease symptoms
as well as the formation of inflammatory foci in infected lungs.
Thus, the absence of greater than 90% of alveolar macrophages
did not inhibit early host signaling that leads to the massive influx
of neutrophils into the lung during pulmonary Y. pestis infection.
This indicates that either the remaining number of alveolar
macrophages is sufficient, or an additional cell type is responsible
for this early host response.
Neutrophils have been shown to play a fundamental role in
protecting the host during pulmonary infection with a number of
organisms, including Streptococcus pneumoniae, Klebsiella pneumoniae,
and Legionella pneumophila [26,27,28,29]. We hypothesized that
deleting these key mediators of innate immunity would signifi-
cantly exacerbate disease progression. Surprisingly, depletion of
neutrophils had little to no effect on bacterial burden in the lung.
This is in contrast to what has been reported previously, as Laws et
al. reported a modest increase in bacterial titers in lungs of infected
mice early after neutrophil depletion [30]. Differences in mouse
lines and Y. pestis strains may have contributed to this disparity, as
this group utilized a strain of Y. pestis that has poor fitness in the
lung, as demonstrated by a decrease in bacterial burden by 24 hpi
[30]. The unaltered pattern of bacterial proliferation in the lungs
of neutrophil-depleted mice indicates that fully virulent Y. pestis is
highly resistant to the antimicrobial effects of neutrophils that are
recruited in response to infection. In support of this, the presence
of the Y. pestis T3SS has been shown to be important for resisting
Host Targets of Yersinia during Pneumonic Plague
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neutrophil-mediated killing by inhibiting phagocytosis and re-
pressing reactive oxygen species production [31]. Also, gene
expression profiling in neutrophils exposed to Y. pestis indicated
that the T3SS suppresses the activation of a number of genes
responsible for pro-inflammatory cytokine output and prolonged
cell survival [32]. Surprisingly, infected animals pre-treated with
neutrophil-depleting antibody did not demonstrate outward signs
of disease at 48 hpi despite significant bacterial burdens, indicating
a failure to fully progress into the pro-inflammatory phase of
pneumonia. Upon histological examination, the small sporadic
foci that were detected in the lungs of these animals were primarily
made up of alveolar-residing bacteria and a relatively small
number of mononuclear cells and neutrophils. These animals
eventually succumbed, not from the typical lung inflammation and
pathology of pneumonic plague, but as a result of the unhindered
spread of Y. pestis to other tissues of the body.
The information gathered in this study supports a model of the
pre-inflammatory phase of pneumonic plague where Y. pestis
initially targets resident alveolar macrophages and then neutro-
phils to facilitate proliferation in the lung. As neutrophils are
unable to sufficiently control Y. pestis, their continued chemotaxis
results in the formation of massive inflammatory foci and causes
severe damage to the alveolar architecture of the lung. Work
evaluating the fate of injected macrophages and neutrophils will
provide insight into the downstream signaling events that lead to
progression into the pro-inflammatory phase of disease.
In summary, the work presented here is the first to identify
target host cells and evaluate population dynamics in the lung
during primary pneumonic plague. Though much of the previous
literature in the field highlights interactions between Y. pestis and
macrophages, we show that Y. pestis primarily targets neutrophils
early after inoculation in the lung, presumably to limit host innate
immune mechanisms aimed at bacterial killing and clearance. To
our surprise, depletion of neutrophils, a key innate immune
mechanism for controlling infection during pneumonia, attenuat-
ed much of the intense inflammation seen in the lung during the
pro-inflammatory phase of disease. Thus, neutrophils appear to be
key players in the manifestation of what is ultimately a host-
mediated necrotizing pneumonia. Understanding the early delay
in innate immune response is crucial to understanding the events
that ultimately lead to the progression of this highly lethal
syndrome. Further, therapy targeting both bacterial growth as well
as the destructive capacity of neutrophils in the lung may be key to
expanding the time window during which treatment can be
administered during pneumonic plague.
Materials and Methods
Ethics statement
The use of live vertebrate animals was performed in accordance
with the Public Health Service (PHS) policy on Humane Care and
Use of Laboratory Animals, the Amended Animal Welfare Act of
1985, and the regulations of the United States Department of
Agriculture (USDA). All animal studies were approved by the
University of North Carolina at Chapel Hill Office of Animal Care
and Use, protocol #09-057.0.
Bacterial strains and culture conditions
The fully virulent Yersinia pestis strain CO92 was obtained from
the U.S. Army, Ft. Detrick, MD. Y. pestis strains were grown on
brain-heart infusion (BHI) agar (Difco Laboratories) at 26uC for
two days. For infections, liquid cultures of Y. pestis CO92 were
grown in BHI broth for 6–12 h at 26uC. The cultures were then
diluted to an OD620 of 0.05–0.1 in BHI supplemented with
2.5 mM CaCl2 and grown 12–16 h at 37uC with constant shaking.
For construction of the YopE-TEM strain, Joan Mecsas (Tufts
University) kindly provided us with plasmid pSR47s-E-TEM
containing the TEM1 portion of b-lactamase from pBR322 fused
to the sequence encoding the promoter plus the first 100 amino
acids of YopE [33]. Plasmid pSR47s-E-TEM was transferred into
Y. pestis CO92 from Escherichia coli S17 harboring pSR47-E-TEM
via bacterial conjugation in the presence of 10 mM MgSO4,
followed by growth on BHI agar containing kanamycin (75 mg/
mL) and Polymyxin B (25 mg/mL) to select for Y. pestis conjugates.
Single-copy integration of the plasmid results in two copies of yopE:
one copy consisting of the native YopE promoter driving the TEM
reporter, followed by plasmid sequence and the intact YopE
promoter present on the plasmid driving a wild-type YopE open
reading frame.
Animals and animal infections
Six to eight-week-old female C57BL/6J mice were obtained
from Jackson Laboratories. Mice were provided with food and
water ad libitum and maintained at 25uC and 15% humidity with
alternating 12 h periods of light and dark. For animal infections,
groups of four to five mice were lightly anesthetized with
ketamine/xylazine and inoculated intranasally with the lethal
dose of 104 colony forming units (CFU) suspended in 20 mL PBS.
A dose of 106 CFUs was necessary for analysis of YopE injection
in order to assure sufficient detection in vivo at early time points.
Numbers of CFUs were determined by plating serial dilutions of
the inoculum on BHI. Moribund animals were euthanized with an
overdose of sodium pentobarbital. For determination of bacterial
burden, lungs were removed at the indicated times and
homogenized in 1 mL PBS using an Omni Tissue Tearer. Serial
dilutions of each organ homogenate were plated on BHI agar and
reported as CFU/lung.
Depletion of innate immune cell populations
For depletion of neutrophils, mice were inoculated via tail vein
injection with 20 mg LEAF purified anti-mouse Ly-6G Ab clone
1A8 (Biolegend) diluted in 100 ml PBS 24 hours prior to infection.
For depletion of alveolar macrophage populations, mice were
anaesthetized with katamine/xylazine and clodrosome (Encapsula
NanoSciences) or manufacturer-provided control liposomes were
delivered intranasally in five successive 15-mL doses. This process
was repeated 24 h later, and mice were typically infected 24 hours
after the second treatment. For both neutrophil and alveolar
macrophage depletion, mice were sacrificed at various times post-
inoculation, and lung cells were analyzed by flow cytometry (see
below) to evaluate the presence/absence of the appropriate cell
types.
Histopathology
Groups of three mice were inoculated intranasally as described
above, and lungs were inflated with 1 mL of 10% neutral buffered
formalin via tracheal cannulation, then removed and incubated in
10% formalin for a minimum of 12 h. Lungs were washed once in
PBS for 2 hours, immersed in 70% EtOH, and embedded in
paraffin. Three five-micrometer sections 200 mm apart per lung
were stained with hematoxylin/eosin for examination.
To evaluate the average area of inflammation, images were
taken at 46 magnification from inflamed mouse lung sections
(three sections per mouse) from at least six mice per treatment
condition (untreated, antibody-treated, or clodrosome-treated)
from two independent experiments. A total of 30 sections per
each treatment condition were examined and inflammatory lesions
were defined and area was quantified using ImageJ software [34].
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Generating single-cell suspensions from lungs
For generating a lung single-cell suspension for flow cytometry,
mice were euthanized with an overdose of sodium pentobarbital,
and the hepatic portal vein was cut and bled. The tracheas were
cannulated with a 22G catheter, and lungs were inflated with 1 mL
(5 U/mL) Dispase I (BD Biosciences) [13]. Tracheas were tied off
with silk thread, and lungs were removed and incubated in Dispase I
(5 U/mL) at room temperature for 25 minutes. Lungs were then
placed in a petri plate with PBS-DNase I (100 mg/mL, Sigma), and
tissue was teased apart using forceps. At this point the trachea and
surrounding connective tissue were removed. When most of the
tissue was disrupted into suspension, cells were gently swirled for
1 minute, followed by passage through a 100-mm nylon cell strainer
(BD Falcon). Filtered suspensions were spun at 5006g for 5 minutes
at 4uC, then resuspended in 1 mL red blood cell lysis solution
(0.15 M NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). After incuba-
tion at room temperature for 2 minutes, 9 mL PBS was added to
neutralize osmolarity, and cells were pelleted as above for staining.
Staining of lung cell suspensions for flow cytometry
After red blood cell lysis, cell suspensions from each animal were
resuspended in 100 mL of 2.4G2 hybridoma supernatant and
incubated at room temperature for 20 minutes to block macro-
phage Fc receptors. Cell suspensions were then pelleted at 5006g
for five minutes at 4uC. Cells were resuspended and incubated for
30 minutes at 4uC with the following fluorescent labeled
antibodies in flow cytometry buffer (2% fetal bovine serum in
PBS) for staining of cell surface markers (1:100 dilutions): CD11b-
phyoerythrin (Clone M1/70.15; Invitrogen), CD11c-phycoery-
thrin-Texas Red (Clone N418; Invitrogen), Ly6G-phycoerythrin-
Cy7 (Clone 1A8; BD Bioscience), LIVE/DEAD fixable aqua dead
cell stain (Clone L34957; Invitrogen), and F4/80-allophycocyanin
(Clone BM8; Biolegend). Stained cells were analyzed based
on fluorescence staining patterns to identify alveolar macro-
phages (F4/80+CD11bmid/lowCD11chigh), CD11bhigh interstitial/
exudate macrophages (F4/80+CD11bhighCD11clow/mid), F4/
80+CD11bhigh CD11chigh macrophages, monocytes (F4/
802CD11bhighCD11clowLy-6G2), CD11bhigh and CD11blow den-
dritic cells (F4/802CD11chighCD11bhigh or low), and neutrophils
(F4/802CD11clowCD11bhighLy-6G+) [11,12,13,14,23]. In the
absence of CCF2-AM addition, 500 mL PBS was added to
samples, followed by centrifugation at 5006g at 4uC and fixation
as described below. For addition of CCF2-AM substrate after
antibody staining, we prepared 66CCF2-AM in loading solution
(Invitrogen) per manufacturer’s instructions, which was diluted
into each sample to a final 16 concentration. After incubation at
room temperature for 30 minutes, the samples were diluted with
PBS and centrifuged at 5006g at 4uC. Cells were then
resuspended in 2% formalin and incubated at room temperature
for 15 minutes for fixation, followed by centrifugation and
resuspension in PBS with gentamicin for removal from the
Biosafety Level 3 laboratory.
Supporting Information
Figure S1 Y. pestis primarily targets CD32CD45+ innate
immune cells for injection of YopE-TEM. To discriminate
between epithelial/endothelial (CD32CD452), innate immune
leukocyte (CD32CD45+), and lymphocyte (CD3+CD45+) cell
populations, lungs were harvested from groups of mice (n = 3)
inoculated with 106 CFU Y. pestis YopE-TEM, and stained with
antibodies against CD3 and CD45. Samples were analyzed by
flow cytometry to discern (A) percentage of each population
represented in total recovered cells, (B) the percentage of injected
cells represented by each cell type, and (C) the percentage of each
cell population demonstrating blue fluorescence, and therefore
injection of YopE-TEM. Data is representative of at least two
independent experiments. Error bars represent SEM.
(TIFF)
Figure S2 Identifying and evaluating the host cell
repertoire during Y. pestis pulmonary infection. (A) For
identification of host-cell types, digested lung homogenates were
stained with fluorescent antibodies against F4/80, CD11b,
CD11c, and Ly-6G. The gating strategy used to identify various
host cell types is shown in representative histograms of data from
an uninfected mouse: G1 = interstitial macrophages;
G2 = CD11b+CD11c+ cells; G3 = alveolar macrophages;
G4 = CD11bHigh DCs; G5 = CD11bLow DCs; G6 = monocytes;
G7 = neutrophils. (B) The percentage of each of the cell types
demonstrating YopE-TEM injection (blue fluorescence) at 6, 12,
and 24 hpi was evaluated by flow cytometry; Data are
representative of at least three independent experiments with five
mice at each time point. Error bars represent SEM.
(TIFF)
Figure S3 Depletion of alveolar macrophages with
clodrosome. Cells from lungs of mice treated or untreated with
clodrosome were harvested and analyzed by flow cytometry 48 h
after the first of two treatments to evaluate alveolar macrophage
(F4/80+CD11blow/midCD11chigh) populations. (A) Histograms
show F4/80+ populations from for a single representative mouse
(B) Bar graphs show quantitation of host cell types in PBS (mock)-
treated animals or animals treated with clodrosome from a
representative of experiments repeated at least twice.
(TIFF)
Figure S4 Depletion of neutrophils with a-Ly-6G anti-
body. Cells from lungs of mice treated with a-Ly-6G antibody, or
left untreated, were analyzed for CD11b and Ly-6G expression by
flow cytometry 24 h after treatment to evaluate neutrophil
(CD11b+Ly-6G+) populations. (A) Histograms show F4/
802CD11c2 populations from a single representative mouse; (B)
Bar graphs show quantitation of host cell types in PBS (mock)-
treated animals or animals treated 24 h prior with a-Ly-6G from a
representative of experiments repeated at least twice.
(TIFF)
Figure S5 Evaluating infected mice treated with a-Ly-
6G antibody or Clodrosome. (A) Mice (n = 10) were left
untreated, or pretreated with a-Ly-6G antibody or Clodrosome
followed by inoculation with 104 CFU Y. pestis CO92. Infected
mice were monitored for disease symptoms and were sacrificed
when moribund. (B) The lungs of mice inoculated with 104 CFU
Y. pestis CO92 and treated with a-Ly-6G antibody or clodrosome
were harvested at 48 hpi and processed for H and E staining.
Lung sections showing inflamed regions were analyzed to calculate
the area occupied by inflammatory foci using ImageJ software.
Bars represent the area (mm2) of inflammation per field in three
sections from at least six mice. The mean inflamed area from a
total of 30 fields per treatment condition are shown. Asterisks
indicate a significant difference in area between sample conditions
(* = ,.001, ** = ,.0001 by two-way ANOVA).
(TIFF)
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